![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-desktop-header-1gif-4289.gif)
![AbbVie Header](https://www.pharmacompass.com/image/flap/abbvie-header-w29-mobgif-81230.gif)
X
20
Kern Pharma, S.l. Terrassa Es, based in Spain, is a pharmaceutical company.
One of their significant offerings is Sufentanil citrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-088 - Rev 01
This Chemical Type CEP, issued on May 22, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1269 associated with this CEP further emphasizes